These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17195477)

  • 21. The evolution of bioinformatics in toxicology: advancing toxicogenomics.
    Afshari CA; Hamadeh HK; Bushel PR
    Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S225-37. PubMed ID: 21177775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA microarrays as a tool in toxicogenomics.
    de Longueville F; Bertholet V; Remacle J
    Comb Chem High Throughput Screen; 2004 May; 7(3):207-11. PubMed ID: 15134526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells.
    Li HH; Hyduke DR; Chen R; Heard P; Yauk CL; Aubrecht J; Fornace AJ
    Environ Mol Mutagen; 2015 Jul; 56(6):505-19. PubMed ID: 25733355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new Transcriptional Effect Level Index (TELI) for toxicogenomics-based toxicity assessment.
    Gou N; Gu AZ
    Environ Sci Technol; 2011 Jun; 45(12):5410-7. PubMed ID: 21612275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus recommendations to promote and advance predictive systems toxicology and toxicogenomics.
    Waters M; Yauk C
    Environ Mol Mutagen; 2007 Jun; 48(5):400-3. PubMed ID: 17567851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs.
    Jacobs A
    Toxicol Lett; 2009 Apr; 186(1):32-5. PubMed ID: 18809476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The state-of-the-art in predictive toxicogenomics.
    Fielden MR; Kolaja KL
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental toxicogenomics: a post-genomic approach to analysing biological responses to environmental toxins.
    Jayapal M; Bhattacharjee RN; Melendez AJ; Hande MP
    Int J Biochem Cell Biol; 2010 Feb; 42(2):230-40. PubMed ID: 19836462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward a public toxicogenomics capability for supporting predictive toxicology: survey of current resources and chemical indexing of experiments in GEO and ArrayExpress.
    Williams-Devane CR; Wolf MA; Richard AM
    Toxicol Sci; 2009 Jun; 109(2):358-71. PubMed ID: 19332651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The promise of toxicogenomics for genetic toxicology: past, present and future.
    David R
    Mutagenesis; 2020 Mar; 35(2):153-159. PubMed ID: 32087008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systems toxicology used in nanotoxicology: mechanistic insights into the hepatotoxicity of nano-copper particles from toxicogenomics.
    Yang B; Wang Q; Lei R; Wu C; Shi C; Wang Q; Yuan Y; Wang Y; Luo Y; Hu Z; Ma H; Liao M
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8527-37. PubMed ID: 21121362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicogenomics.
    Gomase VS; Tagore S
    Curr Drug Metab; 2008 Mar; 9(3):250-4. PubMed ID: 18336230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicogenomics and systems toxicology: aims and prospects.
    Waters MD; Fostel JM
    Nat Rev Genet; 2004 Dec; 5(12):936-48. PubMed ID: 15573125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA; Bruno ME
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective.
    Vahle JL; Anderson U; Blomme EAG; Hoflack JC; Stiehl DP
    Regul Toxicol Pharmacol; 2018 Jul; 96():18-29. PubMed ID: 29679677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.